The dose of hydroxyethyl starch 6% 130/0.4 for fluid therapy and the incidence of acute kidney injury after cardiac surgery: A retrospective matched study.
The safety of hydroxyethyl starches (HES) is still under debate. No studies have compared different dosing regimens of HES in cardiac surgery. We analyzed whether the incidence of Acute Kidney Injury (AKI) differed taking into account a weight-adjusted cumulative dose of HES 6% 130/0.4 for periopera...
Main Authors: | Mona Momeni, Lompoli Nkoy Ena, Michel Van Dyck, Amine Matta, David Kahn, Dominique Thiry, André Grégoire, Christine Watremez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5646817?pdf=render |
Similar Items
-
Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
by: Chung-Sik Oh, et al.
Published: (2012-04-01) -
Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4
by: Ornella Piazza, et al.
Published: (2010-09-01) -
Mortality after hydroxyethyl starch 130/0.4 infusion: an updated meta-analysis of randomized trials
by: Christian Josef Wiedermann, et al.
Published: (2012-07-01) -
Hydroxyethyl starch 130/0.4 and sodium chloride injection as adjunctive therapy in patients with cerebral hypoperfusion
by: Han Junliang, et al.
Published: (2012-10-01) -
Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited
by: Christian J. Wiedermann
Published: (2022-04-01)